세계의 판막 성형 시스템 시장 보고서(2025년)
Annuloplasty System Global Market Report 2025
상품코드 : 1760457
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,546,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,462,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,378,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

판막 성형 시스템 시장 규모는 향후 수 년간 강력한 성장이 전망될 예정입니다. 예측 기간의 성장은 최소 침습적 기법의 채택 증가, 경피적 판륜 성형술의 확대, 심혈관 질환의 전 세계 유병률 증가, 개인 맞춤형 의학에 대한 수요 증가, 생체 재료에 대한 지속적인 연구 발전에 기인할 수 있습니다. 예측 기간 중의 주요 동향으로는 수술 계획에 있어서의 인공지능 통합, 생체 흡수성 환상 성형술 링 개발, 로봇 지원에 의한 심장 밸브 수복술의 대두, 커스터마이즈 임플란트를 위한 3차원(3D) 프린팅 사용 증가, 외래 심장 수술 중시 등을 들 수 있습니다.

심혈관 질환의 유병률의 상승은 향후의 판막 성형 시스템 시장의 성장을 가속할 것으로 예측됩니다. 이러한 증가는 주로 고령화 인구에 기인하며, 나이가 들면서 심장과 혈관의 자연스러운 마모가 심장 질환의 위험을 증가시키기 때문입니다. 이러한 시스템은 판막 복원을 위한 최소 침습 옵션을 제공하여 회복 시간을 단축하고 수술 위험을 줄임으로써 환자 결과를 개선합니다. 2023년 12월 호주의 정부 기관인 호주 보건복지연구소는 관상동맥 심장 질환(CHD)으로 인한 의사 인증 사망자가 2021년 1만4,100명에서 2022년에는 1만4,900명으로 증가했다고 보고했습니다.

판막 성형 시스템 시장의 주요 기업은 수술 효율성과 장기적인 환자 결과를 개선하기 위해 차세대 수술 밸브 및 장치와 같은 혁신적인 제품 개발에 주력하고 있습니다. 차세대 수술용 밸브 및 장치는 이식을 단순화하고 수술의 복잡성을 줄이고 밸브 수리 및 교체의 정확성과 내구성을 높이기 위해 고안된 첨단 의료 기술입니다. 메드트로닉 사는 차세대 수술용 대동맥 조직 밸브인 아발라스 울트라 밸브를 발표했습니다. 베이스 프레임은 이식을 용이하게 하고, 수술의 용이함과 장기적인 기능성을 향상시키고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

An annuloplasty system is a medical device utilized in heart valve repair surgeries, primarily to treat valve dysfunction. It consists of a ring or band that is placed around the heart valve annulus to reshape or strengthen it, ensuring the valve closes properly. This device helps restore normal valve function and prevents the backward flow of blood within the heart, thereby enhancing heart performance and patient outcomes.

The main types of annuloplasty systems include annular rings and bands, as well as suture annuloplasty devices. Annular rings and bands are implantable devices used in heart valve repair surgeries, especially during annuloplasty procedures. These procedures may be performed via open-heart surgery, minimally invasive techniques, or robot-assisted methods. Annuloplasty systems are applied to various heart valves, including the mitral, tricuspid, aortic, and pulmonary valves, serving end users such as hospitals, ambulatory surgical centers, and cardiac care facilities.

The annuloplasty system market research report is one of a series of new reports from The Business Research Company that provides annuloplasty system market statistics, including annuloplasty system industry global market size, regional shares, competitors with a annuloplasty system market share, detailed annuloplasty system market segments, market trends and opportunities, and any further data you may need to thrive in the annuloplasty system industry. This annuloplasty system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The annuloplasty system market size has grown strongly in recent years. It will grow from $0.65 billion in 2024 to $0.70 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be attributed to an increasing aging population, a rising prevalence of valvular heart diseases, greater adoption of minimally invasive surgical techniques, increased healthcare spending, and the expansion of cardiovascular specialty centers.

The annuloplasty system market size is expected to see strong growth in the next few years. It will grow to $0.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to the increasing adoption of minimally invasive techniques, the expansion of transcatheter annuloplasty procedures, the rising global prevalence of cardiovascular diseases, growing demand for personalized medicine, and ongoing research advancements in biomaterials. Key trends during the forecast period include the integration of artificial intelligence in surgical planning, the development of bioabsorbable annuloplasty rings, the rise of robotic-assisted heart valve repairs, the increased use of three-dimensional (3D) printing for customized implants, and a greater focus on outpatient cardiac procedures.

The rising prevalence of cardiovascular diseases is expected to drive growth in the annuloplasty system market in the future. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including coronary heart disease, heart failure, stroke, and hypertension. This increase is largely attributed to the aging population, as the natural wear and tear on the heart and blood vessels with age raises the risk of heart conditions. Annuloplasty systems assist in treating cardiovascular diseases by offering effective solutions for heart valve repair, restoring proper valve function, and improving blood flow. These systems improve patient outcomes by providing minimally invasive options for valve restoration, which reduces recovery time and lowers surgical risks. For example, in December 2023, the Australian Institute of Health and Welfare, a government agency in Australia, reported that doctor-certified deaths from coronary heart disease (CHD) increased from 14,100 in 2021 to 14,900 in 2022. Hence, the growing prevalence of cardiovascular diseases is fueling the growth of the annuloplasty system market.

Leading companies in the annuloplasty system market are focusing on developing innovative products such as next-generation surgical valves and devices to improve procedural efficiency and long-term patient outcomes. These next-generation surgical valves and devices are advanced medical technologies designed to simplify implantation, reduce surgical complexity, and enhance the precision and durability of valve repairs or replacements. For instance, in June 2024, Medtronic plc, a US-based medical technology firm, introduced the Avalus Ultra valve, a next-generation surgical aortic tissue valve. This device facilitates easier implantation with its low-profile valve holder and durable polyetheretherketone (PEEK) base frame, improving surgical ease and long-term functionality. It also enhances blood flow dynamics and offers visibility for future valve-in-valve procedures.

In July 2024, Affluent Medical SAS, a medical device company based in France, acquired Edwards Lifesciences Corporation for $16.3 million. This acquisition aims to expand Affluent Medical's presence in the cardiovascular market by strengthening its portfolio of heart valve solutions. It aligns with the company's strategic goal to accelerate the development of advanced therapies for heart disease and improve patient outcomes. Edwards Lifesciences is a US-based medical technology company specializing in annuloplasty systems for mitral and tricuspid valve repair to support heart valve restoration.

Major players in the annuloplasty system market are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Mesungen AG, Terumo Corporation, Edwards Lifesciences Corporation, LivaNova PLC, MicroPort Scientific Corporation, B.Braile Biomedica, Affluent Medical, Micro Interventional Devices Inc., NeoChord Inc., Labcor Laboratories Ltd., BioVentrix Inc., CryoLife Inc., Genesse BioMedical, BioStable Science & Engineering Inc., FOC Medical S.A, and Cardiac Implants LLC.

North America was the largest region in the annuloplasty system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in annuloplasty system report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the annuloplasty system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The annuloplasty system market consists of sales of flexible annuloplasty rings, rigid annuloplasty rings, semi-rigid rings, adjustable bands, surgical tools, implantable devices, and associated accessories used in heart valve repair procedures. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Annuloplasty System Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on annuloplasty system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for annuloplasty system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The annuloplasty system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Annuloplasty System Market Characteristics

3. Annuloplasty System Market Trends And Strategies

4. Annuloplasty System Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Annuloplasty System Growth Analysis And Strategic Analysis Framework

6. Annuloplasty System Market Segmentation

7. Annuloplasty System Market Regional And Country Analysis

8. Asia-Pacific Annuloplasty System Market

9. China Annuloplasty System Market

10. India Annuloplasty System Market

11. Japan Annuloplasty System Market

12. Australia Annuloplasty System Market

13. Indonesia Annuloplasty System Market

14. South Korea Annuloplasty System Market

15. Western Europe Annuloplasty System Market

16. UK Annuloplasty System Market

17. Germany Annuloplasty System Market

18. France Annuloplasty System Market

19. Italy Annuloplasty System Market

20. Spain Annuloplasty System Market

21. Eastern Europe Annuloplasty System Market

22. Russia Annuloplasty System Market

23. North America Annuloplasty System Market

24. USA Annuloplasty System Market

25. Canada Annuloplasty System Market

26. South America Annuloplasty System Market

27. Brazil Annuloplasty System Market

28. Middle East Annuloplasty System Market

29. Africa Annuloplasty System Market

30. Annuloplasty System Market Competitive Landscape And Company Profiles

31. Annuloplasty System Market Other Major And Innovative Companies

32. Global Annuloplasty System Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Annuloplasty System Market

34. Recent Developments In The Annuloplasty System Market

35. Annuloplasty System Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기